IE
Insider Edges

GILEAD SCIENCES, INC. 13F portfolio summary

GILEAD SCIENCES, INC. of GILEAD SCIENCES, INC. has 5 current stock holdings with a reported portfolio value of $1.65B. The portfolio 1 year return is +90.54%. Top holdings include RCUS (58.76%), GLPG (30.34%).

Back to investors

GILEAD SCIENCES, INC. 13F Portfolio

GILEAD SCIENCES, INC.
Latest SEC 13F filing: 2026-06-30

GILEAD SCIENCES, INC. runs GILEAD SCIENCES, INC. and currently holds 5 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $1.65B. Their top holdings are RCUS, GLPG. The top five represent 89.1% of reported portfolio weight. GILEAD SCIENCES, INC. ranks #N/A out of 1000 investors tracked by Alpha Score. Their current best-performing preview position is RCUS with returns of +42.73%.

Sign in to enable email alerts for this investor.
Top 5 Holdings
RCUS58.8%
GLPG30.3%
Top 5: 89.1%
Portfolio Returns
1 Year
+90.54%
#0/1000
3 Year
+56.71%
#0/1000
5 Year
+56.71%
#0/1000

Portfolio Value

$1.65B

Alpha Score

59.2

#0 of 1000

Holdings

5

Showper page

GILEAD SCIENCES, INC. Current 13F Holdings

Reported holdings from GILEAD SCIENCES, INC.'s latest SEC 13F filing, ranked by portfolio weight.

5 stock holdings

HoldingWeightAvg BuyCurrentReturnQuarter Change
RCUS
Arcus Biosciences Inc.
58.76%$14.58$24.42+67.49%
Held
GLPG
Lakefront Biotherapeutics
30.34%$27.50$27.98+1.75%
Held